Fidelity National Financial, Inc. Announces Commencement of Consent Solicitation

Rhea-AI Summary

Fidelity National Financial (NYSE: FNF) has initiated consent solicitations for holders of its senior notes due 2028, 2030, 2031, and 2051, seeking approval to amend the indenture to allow redomestication from Delaware to Nevada. The total outstanding notes amount to $2.15 billion. FNF is offering a consent fee of $1.00 per $1,000 principal amount to holders who approve by June 3, 2025. This follows a similar attempt in 2024 that received noteholder consent but failed to secure shareholder approval. The redomestication requires majority consent from each note series and shareholder approval. FNF states the redomestication would not impact its business operations, revenues, income, or cash flows, and maintains the option to pursue redomestication through alternative methods like merger if the consent solicitations fail.

Positive

• FNF maintains flexibility by having alternative methods to achieve redomestication if consent solicitation fails
• Company offering financial incentive ($1.00 per $1,000) to noteholders for consent
• Redomestication not expected to impact business operations, revenues, or cash flows

Negative

• Second attempt at redomestication after failing to secure shareholder approval in 2024
• Complex process requiring multiple approvals from different noteholder groups
• Consent fee only payable if redomestication is completed

Insights

Corporate Restructuring Specialist

FNF seeks bondholder approval for Delaware-to-Nevada redomestication, offering $1/1000 consent fee; structural change with minimal operational impact.

FNF has initiated consent solicitations for holders of four series of senior notes to amend the indenture governing these securities. The amendment would allow FNF to redomesticate from Delaware to Nevada via corporate conversion - essentially changing its legal domicile while maintaining its business operations.

This is FNF's second attempt at this redomestication. In April 2024, the company secured bondholder approval but failed to obtain shareholder consent, causing the initiative to be abandoned. The company's board continues to believe this change is in shareholders' best interests, prompting this renewed effort.

The consent solicitation covers $2.15 billion in total debt across four note series: $450 million of 4.500% notes due 2028, $650 million of 3.400% notes due 2030, $600 million of 2.450% notes due 2031, and $450 million of 3.200% notes due 2051. Bondholders who provide consent by the June 3, 2025 deadline will receive a consent fee of $1.00 per $1,000 in principal, payable only if the redomestication is completed.

What makes this interesting is the company's explicit statement that the redomestication would not impact its "business, properties, assets, liabilities, obligations or management" or affect its "reported revenues, income or cash flows." This suggests the move is primarily driven by legal or tax considerations rather than operational strategy.

The company has positioned this as a flexible process - if bondholders don't approve the amendment, FNF indicates it might still pursue redomestication through alternative means such as a merger structure, which wouldn't require bondholder consent under the current indenture. This demonstrates management's determination to complete this jurisdictional change despite potential obstacles.

JACKSONVILLE, Fla., May 28, 2025 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE: FNF) ("FNF" or the "Company") today announced the commencement of separate and distinct consent solicitations of the holders of each of its 4.500% Senior Notes due 2028 (the "2028 Notes"), 3.400% Senior Notes due 2030 (the "2030 Notes"), 2.450% Senior Notes due 2031 (the "2031 Notes") and 3.200% Senior Notes due 2051 (the "2051 Notes" and, collectively with the 2028 Notes, 2030 Notes and the 2031 Notes, the "Notes"; and each a "series of Notes") to effect a certain amendment to the indenture governing the Notes (the "Indenture") with respect to each series of Notes, as described below. As of May 27, 2025, there was $450,000,000 aggregate principal amount of 2028 Notes outstanding, $650,000,000 aggregate principal amount of the 2030 Notes outstanding, $600,000,000 aggregate principal amount of the 2031 Notes outstanding and $450,000,000 aggregate principal amount of the 2051 Notes outstanding.

The proposed amendment to the Indenture would add a clause to the corporate existence covenant permitting the Company to redomesticate, by conversion, from a corporation organized under the laws of the State of Delaware to a corporation organized under the laws of the State of Nevada (the "Redomestication"). The Redomestication is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2025, as the same may be supplemented, modified or amended prior to the vote of the Company's shareholders contemplated thereby (the "Proxy Statement"). All other terms of the Indenture will remain unchanged. The Company believes that there are important reasons the Redomestication is in the best interest of the Company and its shareholders, which are discussed in the Consent Solicitation Statement (as defined below) and set forth in detail in the Proxy Statement. FNF does not believe there will be any change in FNF's business, properties, assets, liabilities, obligations or management because of the Redomestication, or that the Redomestication would impact FNF's reported revenues, income or cash flows.

In April 2024, the Company solicited and received the consent of each series of Notes to make an amendment to the Indenture related to a redomestication proposal (the "2024 Consent Solicitations"); however, it did not receive the approval of its shareholders to consummate the Redomestication. Therefore, the Redomestication was abandoned prior to its consummation. As a result, no amendment to the Indenture became operative in 2024. Since the Board of Directors continues to believe there are many important reasons the Redomestication is advisable and in the best interests of the Company, the Company has decided to again seek approvals for the Redomestication.

The Consent Solicitation is on the same terms in all respects (including as to the Consent Fee) as the 2024 Consent Solicitations.

Each consent solicitation will expire at 5:00 p.m., New York City time, on June 3, 2025, unless extended or earlier terminated by the Company in its sole discretion (such date and time, as the same may be extended with respect to any series of notes, the applicable "Expiration Time"). Each of the consent solicitations is subject to the terms and conditions set forth in the consent solicitation statement, dated May 28, 2025 (the "Consent Solicitation Statement").

The Company is offering to pay holders who validly deliver their consents at or prior to the applicable Expiration Time (and do not validly revoke such consents) a consent fee payable only immediately prior to consummation of the Redomestication of $1.00 in cash per $1,000 principal amount of Notes (the "Consent Fee"). No Consent Fee will be paid with respect to a series of Notes if the applicable Requisite Consents (as defined below) for such series of Notes are not received, if the applicable consent solicitation is terminated prior to the applicable Effective Time (as defined below) or if the Company abandons the Redomestication or if it is not completed for any reason whatsoever. The Company is not required to consummate the Redomestication even if it has received the Requisite Consent for any or all series of Notes and the approval of its shareholders to the Redomestication. If the Redomestication is abandoned prior to consummation or otherwise not completed for any reason whatsoever (including, without limitation, because the Company determines to effect a redomestication by way of merger or otherwise), or the conditions to these consent solicitations are not satisfied or waived, then no Consent Fee shall be payable.

The Company has determined to proceed with the Redomestication by way of a conversion to a Nevada corporation. However, a redomestication from Delaware to Nevada can be achieved using other transaction structures, including by way of a merger with a Nevada corporation. The Company's Indenture would not prevent such a merger and, if any of the consent solicitations are not successful, the Company reserves the right in its sole discretion to consider effecting a redomestication by way of merger (or such other transaction structure as may be permitted by the Indenture) and not seek the consent of holders for any series of Notes pursuant to the consent solicitations. In that case, no Consent Fee would be paid with respect to any series of Notes if a redomestication is so effected, even if a supplemental indenture for such series of Notes has become effective.

Holders of the Notes may revoke their consents at any time prior to the applicable Expiration Time or, if earlier, the Effective Time. The "Effective Time" means, for any series of Notes, the first time at which valid consents in respect of a majority in principal amount of the 2028 Notes, 2030 Notes, 2031 Notes and 2051 Notes, as applicable, have been received by the Company to approve the proposed amendment, and have not prior to such time been revoked. If adopted, non-consenting holders of Notes of each applicable series will be bound by the amendment to the Indenture but will not receive the Consent Fee.

Approval of the proposed amendment for each series of Notes requires the consent of the holders of record as of 5:00 p.m., New York City time, on May 27, 2025, of, as applicable, the (i) 2028 Notes representing not less than a majority in aggregate principal amount of all 2028 Notes outstanding, (ii) 2030 Notes representing not less than a majority in aggregate principal amount of all 2030 Notes outstanding, (iii) 2031 Notes representing not less than a majority in aggregate principal amount of all 2031 Notes outstanding and (iv) 2051 Notes representing not less than a majority in aggregate principal amount of all 2051 Notes outstanding (collectively, the "Requisite Consents").

If any of the Requisite Consents are received for one or more series of Notes, then a supplemental indenture with respect to each such series of Notes will be executed and the proposed amendment will become effective with respect to each such series of Notes for which the Requisite Consents were received, regardless of whether any other series of Notes received the consent of less than a majority in aggregate principal amount of such series by such time. However, the proposed amendment with respect to each series of Notes will not become operative with respect to such series of Notes until immediately prior to the consummation of the Redomestication and only if the applicable Consent Fee has been paid to DTC, as the registered holder of the Notes as of the Record Date, no later than the date on which the Redomestication is consummated, the conditions to the consent solicitations are satisfied and the Company accepts such consents. If the Redomestication is abandoned prior to consummation or otherwise not completed for any reason whatsoever (including, without limitation, because the Company determines to effect a redomestication by way of merger or otherwise), or the conditions to the consent solicitations are not satisfied or waived, then no Consent Fee shall be payable.

For a complete statement of the terms and conditions of each consent solicitation, holders of each series of Notes should refer to the Consent Solicitation Statement. The Company may terminate, extend or amend any of the consent solicitations at any time. Each of the consent solicitations is an independent solicitation, is not conditional upon any of the other consent solicitations and can be modified, extended and/or terminated without affecting the terms or conditions of the other consent solicitations.

The Solicitation Agent in connection with the consent solicitations is BofA Securities. Questions regarding the consent solicitations may be directed to BofA Securities, Attention: Liability Management Group at (888) 292-0070 (toll free) or (980) 387-3907 (collect). D.F. King & Co., Inc. is serving as Information Agent and Tabulation Agent in connection with the consent solicitations. Requests for assistance in delivering consents or for additional copies of the Consent Solicitation Statement should be directed to the Information Agent and Tabulation Agent at (866) 340-7108 (toll free) or (212) 269-5550 (banks and brokers) (collect) or by email at fnf@dfking.com.

This announcement is not an offer to purchase, a solicitation of an offer to purchase, or a solicitation of consents with respect to any securities, including the Notes. The consent solicitations are being made solely pursuant to the Consent Solicitation Statement and are subject to the terms and conditions stated therein. No recommendation is made, or has been authorized to be made, as to whether or not holders of the Notes should consent to the adoption of the proposed amendment. The Company reserves the right, in its sole discretion, to terminate or modify any of the consent solicitations.

About Fidelity National Financial, Inc.

Fidelity National Financial, Inc. (NYSE: FNF) is a leading provider of title insurance and transaction services to the real estate and mortgage industries, and a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through its majority owned subsidiary F&G Annuities & Life, Inc. (NYSE: FG). FNF is the nation's largest title insurance company through its title insurance underwriters - Fidelity National Title, Chicago Title, Commonwealth Land Title, Alamo Title and National Title of New York - that collectively issue more title insurance policies than any other title company in the United States. More information about FNF can be found at www.fnf.com.

Forward-Looking Statements and Risk Factors

This press release contains forward-looking statements that involve a number of risks and uncertainties. Statements that are not historical facts, including statements regarding our expectations, hopes, intentions or strategies regarding the future are forward-looking statements. Forward-looking statements are based on management's beliefs, as well as assumptions made by, and information currently available to, management. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The risks and uncertainties which forward-looking statements are subject to include, but are not limited to: the potential impact of the consummation of the Redomestication on relationships, including with shareholders, bondholders and stakeholders; our ability to successfully realize the anticipated benefits of the Redomestication; the risk that we do not receive the Requisite Consents with respect to each series of Notes or shareholder approval for the Redomestication; adverse changes in general economic, business, political crisis, war and pandemic conditions, including ongoing geopolitical conflicts; consumer spending; government spending; the volatility and strength of the capital markets; investor and consumer confidence; foreign currency exchange rates; commodity prices; inflation levels; changes in trade policy; tariffs and trade sanctions on goods; trade wars; supply chain disruptions; weakness or adverse changes in the level of real estate activity, which may be caused by, among other things, high or increasing interest rates, a limited supply of mortgage funding or a weak U.S. economy; our potential inability to find suitable acquisition candidates; our dependence on distributions from our title insurance underwriters as a main source of cash flow; significant competition that F&G and our operating subsidiaries face; compliance with extensive government regulation of our operating subsidiaries, including regulation of title insurance and services and privacy and data protection laws; systems damage, failures, interruptions, cyberattacks and intrusions, or unauthorized data disclosures; and other risks detailed in the "Statement Regarding Forward-Looking Information," "Risk Factors" and other sections of FNF's Form 10-K and other filings with the Securities and Exchange Commission.

FNF-G

View original content:https://www.prnewswire.com/news-releases/fidelity-national-financial-inc-announces-commencement-of-consent-solicitation-302466427.html

SOURCE Fidelity National Financial, Inc.

FAQ

What is FNF seeking approval for in its May 2025 consent solicitation?

FNF is seeking approval from noteholders to amend the indenture to allow redomestication from Delaware to Nevada, offering a consent fee of $1.00 per $1,000 principal amount to holders who approve by June 3, 2025.

How much is the total outstanding amount of FNF's notes affected by this consent solicitation?

The total outstanding amount is $2.15 billion, comprising $450M in 2028 Notes, $650M in 2030 Notes, $600M in 2031 Notes, and $450M in 2051 Notes.

What happens if FNF doesn't receive consent from noteholders?

If consent solicitations fail, FNF reserves the right to pursue redomestication through alternative methods, such as a merger with a Nevada corporation, which would not require noteholder consent.

Will FNF's redomestication affect its business operations?

According to FNF, the redomestication would not impact its business operations, properties, assets, liabilities, obligations, management, reported revenues, income, or cash flows.

Why did FNF's previous redomestication attempt in 2024 fail?

While FNF received noteholder consent in 2024, the redomestication failed because it did not receive the necessary shareholder approval to complete the process.